These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1745429)

  • 1. Cancer and the dynamics of neurodegenerative processes.
    Weiss B
    Neurotoxicology; 1991; 12(3):379-86. PubMed ID: 1745429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on the pathogenesis of neurodegenerative disorders.
    Piccoli F; La Bella V; Guarneri R
    Acta Neurol (Napoli); 1992; 14(4-6):455-68. PubMed ID: 1338180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?
    Blum-Degen D; Frölich L; Hoyer S; Riederer P
    J Neural Transm Suppl; 1995; 46():139-47. PubMed ID: 8821049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].
    Norès JM; Biacabe B; Bonfils P
    Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in neural transplantation. Relevance to neurodegenerative disorders.
    Borlongan CV; Cahill DW; Freeman TB; Sanberg PR
    J Fla Med Assoc; 1994 Oct; 81(10):689-94. PubMed ID: 7798875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, age-related neurodegeneration, and the potential for neurotrophic treatment.
    Williams LR
    Cerebrovasc Brain Metab Rev; 1995; 7(1):55-73. PubMed ID: 7742172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular pathways leading to neuronal dysfunction and degeneration.
    Kazantsev AG
    Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
    Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature].
    Lagodka A; Robert P
    Encephale; 2009 Sep; 35(4):386-93. PubMed ID: 19748376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: autophagy in neurodegeneration: firefighter and/or incendiarist?
    Rami A
    Neuropathol Appl Neurobiol; 2009 Oct; 35(5):449-61. PubMed ID: 19555462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system.
    Iranzo A; Comella CL; Santamaria J; Oertel W
    Mov Disord; 2007; 22 Suppl 18():S424-30. PubMed ID: 17534950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegenerative diseases and model systems.
    Price DL; Borchelt DR; Wong PC; Pardo CA; Thinakaran G; Lee MK; Cleveland DW; Sisodia SS
    Cold Spring Harb Symp Quant Biol; 1996; 61():725-38. PubMed ID: 9246498
    [No Abstract]   [Full Text] [Related]  

  • 16. AIDS dementia complex: a complex, slow virus "model" of acquired genetic neurodegenerative disease.
    Price RW
    Cold Spring Harb Symp Quant Biol; 1996; 61():759-70. PubMed ID: 9246501
    [No Abstract]   [Full Text] [Related]  

  • 17. Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseases.
    Mayer RJ; Lowe J; Lennox G; Doherty F; Landon M
    Prog Clin Biol Res; 1989; 317():809-18. PubMed ID: 2557642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood Disorders in Neurodegenerative Diseases.
    Starkstein SE; Robinson RG
    Semin Clin Neuropsychiatry; 1996 Oct; 1(4):272-281. PubMed ID: 10320430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endogenous factors of neurodestruction (the pharmacologic aspects)].
    Kozlovskiĭ VL
    Farmakol Toksikol; 1990; 53(5):7-13. PubMed ID: 2174797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-ophthalmic manifestations of neurodegenerative disease.
    Pelak VS; Hall DA
    Ophthalmol Clin North Am; 2004 Sep; 17(3):311-20, v. PubMed ID: 15337190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.